Diatos
Paris
About Diatos
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.8M
- Funding stage: Late Stage Venture
- Last round: Series D (Jul 2007)
- Website: diatos.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/diatos-2847519 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.